IP Library Granted Patent US 10,724,067
Granted Patent B2
US 10,724,067 · App. 15/960,049 · Granted Jul 28, 2020

Thermochromic sensing devices, systems, and methods

Inventors: Joerg Martini (San Francisco, CA); Michael Recht (San Carlos, CA); Peter Kiesel (Palo Alto, CA)
Assignee: Palo Alto Research Center Incorporated
C12Q1/025B01L3/5085C12Q1/04C12Q1/10C12Q1/18G01K11/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,724,067
App. No.
15/960,049
Granted
Jul 28, 2020
Kind
B2
Abstract

One or more live substances is cultured at a plurality of test locations of a test vessel. The test locations include a thermochromic material and one or more test substances. A spectral shift in light emanating from the thermochromic material of the test locations is detected. The spectral shift occurs in response to an increase or decrease in energy conversion by the live substance. An effect of the one or more test substances on the live substances is determined based on the detected spectral shift.

Claims (49)

1. A method of detecting an increase or decrease in a metabolism of one or more live substances caused by one or more test substances comprising:

culturing the one or more live substances at a plurality of test locations of a test vessel, the test locations including a thermochromic material and one or more test substances, the thermochromic material configured to react in response to heat generated by the one or more live substances;

detecting a spectral shift in light emanating from the thermochromic material of the test locations, the spectral shift occurring in response to an increase or decrease in the metabolism of the one or more live substances; and

determining an effect of the one or more test substances on the metabolism of the one or more live substances based on the detected spectral shift.

2. The method of claim 1 , further comprising:

monitoring one or more control locations of the test vessel that do not include at least one of the live substances and the test substances;

detecting light emanating from the thermochromic material at the control locations; and

determining the effect of the one or more test substances on the live substances using the detected light from the control locations.

3. The method of claim 1 , wherein the live substance comprises one or more of prokaryotic microorganisms, eukaryotic microorganisms, bacteria, archaea, protists, fungi, plant cells, animal cells, viruses in host cells, phages in host cells, cancer cell culture, and tissue cell culture.

4. The method of claim 1 wherein:

at least some of the test locations include a different concentration of test substance than other test locations; and

determining the effect of the one or more test substances comprises determining at least one concentration of the test substance that is more effective at inhibiting or promoting growth of the live substances than other concentrations of the test substance.

5. The method of claim 1 , wherein:

the one or more test substances comprise one or more types of test substances; and

at least some of the test locations include, a different type of test substance than other test locations; and

determining the effect of the one or more test substances comprises identifying at least one type of test substance that is more effective at inhibiting or promoting growth of the one or more live substances than other types of test substance.

6. The method of claim 1 , wherein:

the one or more test substances comprises one or more combinations of test substances; and

at least some of the test locations include a different combination of test substances than other test locations; and

determining the effect of the one or more test substances comprises identifying at least one combination of test substances that is more effective at inhibiting or promoting growth of the one or more live substances than other combinations of the test substance.

7. The method of claim 1 , wherein:

culturing the one or more live substances comprises culturing a different type of live substance at each test location; and

determining the effect of the one or more test substances comprises determining an effect of one type or one concentration of test substance on the different types of live substances.

8. The method of claim 1 wherein:

the one or more test substances comprise one or more pharmaceuticals;

the test locations include at least one of different types, concentrations, or combinations of the pharmaceuticals; and

determining the effect of the one or more test substances comprises determining at least one of a type, concentration, and combination of the of the pharmaceutical that is effective at inhibiting growth of the live substances.

9. The method of claim 1 , wherein detecting the spectral shift comprises:

dispersing light emanating from the thermochromic material such that a wavelength of the dispersed light varies with respect to distance;

detecting the dispersed light using a one or more photodetectors, the one more photodetectors generating electrical signals responsive to the detected light; and

determining the spectral shift based on ratiometric analysis of the electrical signals.

10. The method of claim 1 , further comprising directing measurement light toward each of the test locations and directing light emanating from the thermochromic material in response to the measurement light at each of the test locations to a photosensing element.

11. A method of detecting an increase or decrease n a metabolism of one or more bacteria caused by one or more antibiotics comprising:

culturing the one or more bacteria at a plurality of test locations of a test vessel, the test locations including a thermochromic material and one or more antibiotics, the thermochromic material configured to react in response to heat generated by the bacteria;

detecting a spectral shift in light emanating from the thermochromic material of the test locations in response to an increase or decrease in the metabolism of the one or more bacteria; and

determining an effect of the one or more antibiotics on the metabolism of the one or more bacteria based on the detected spectral shift.

12. The method of claim 11 , further comprising:

monitoring one or more control locations of the test vessel that do not include at least one of the bacteria and the antibiotic;

detecting light emanating from the thermochromic material at the control locations; and

determining the effect of the one or more antibiotics on the live substances using the detected light from the control locations.

13. The method of claim 11 , wherein:

at least some of the test locations include at least one of a different type, concentration and combination of antibiotics than other test locations; and

determining the effect of the one or more antibiotics comprises determining at least one of a type, concentration, and combination of the antibiotic that is more effective at inhibiting growth of the bacteria than other types, concentrations, or combinations of the antibiotics.

14. The method of claim 11 , wherein determining the effect of the one or more antibiotics comprises determining a minimum inhibitory concentration of the one or more antibiotics.

15. The method of claim 11 , further comprising:

monitoring effects of multiple antibiotics on the bacteria; and

one or more of:

continuously updating a display that shows the effects of the multiple antibiotics; and

generating an alert signal.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073562/0677 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF US PATENTS 9356603, 10026651, 10626048 AND INCLUSION OF US PATENT 7167871 PREVIOUSLY RECORDED ON REEL 064038 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064161/0001 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064038/0001 →